Journal
PATHOLOGY & ONCOLOGY RESEARCH
Volume 16, Issue 1, Pages 111-117Publisher
SPRINGER
DOI: 10.1007/s12253-009-9198-1
Keywords
VE-cadherin; Osteosarcoma cell; Vasculogenic mimicry; siRNA
Funding
- National Natural Science Foundation of China [30271314, 30772182, 30471760]
Ask authors/readers for more resources
Osteosarcoma cells can generate vasculogenic-like, patterned networks to obtain nutrients and oxygen, which mimic some function of endotheial-like cells and facilitate tumor malignant progress. These cells also express vascular endothelial-cadherin (VE-cadherin), which is generally accepted as a strictly endothelial-specific transmembrane protein. However, its role is still relatively obscure in osteosarcoma cells. So we inhibit the VE-cadherin gene expression with siRNA in osteosarcoma cells (MG63), and culture those cells in three-dimensional medium, containing Type I collagen or Matrigel, to observe the role of VE-cadherin. Western blotting analysis show that sequence-specific siRNA can significantly decrease the expression of VE-cadherin in MG63 cell. After knockdown of VE-cadherin, osteosacoma cells cann't induced angiogenic sprout and form osteosarcoma-generated, endotheial-like networks. Our data indicate that VE-cadherin may be a positive and specific regulator not only in angiogenesis, but also in vasculogenic mimicry of osteosarcoma cells. And it can be considered as a new prospective option in the combining treatment of aggressive tumor with highly vascularity, including osteosarcoma.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available